Guangdong Provincial Center for Disease Control and Prevention Report issue

Government Phase 4

Organization Overview

First Clinical Trial
2017
NCT03274102
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Guangdong Provincial Center for Disease Control and Prevention

Active Ingredients

Drugs in Phase 4 Trials (2)

ev71 vaccine (1 trial)

hepatitis b vaccine (recombinant) (Recombivax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Foot-and-Mouth Disease (Phase 4)

Hand, Foot and Mouth Disease (Phase 4)

Mouth Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2